2018 NCRI Cancer Conference

Sunday 4 November – Tuesday 6 November 2018

Programme Details

Sunday 4 November
Sunday, 4 Nov 2018
09:00-19:00
External
2018 BASO – ACS Annual Scientific Conference
Sunday, 4 Nov 2018
13:00-13:15
Armadillo - Clyde Auditorium (G)
Opening speech
Sunday, 4 Nov 2018
13:15-13:55
Armadillo - Clyde Auditorium (G)
Precision oncology
Speaker: Charles Swanton, The Francis Crick Institute, UK
Sunday, 4 Nov 2018
13:55-14:35
Armadillo - Clyde Auditorium (G)
Applying genetic information to prevent colorectal cancer
Speaker: Malcolm Dunlop, University of Edinburgh, UK
Sunday, 4 Nov 2018
14:35-15:15
Armadillo - Clyde Auditorium (G)
Molecular Imaging of Immunotherapies
Speaker: Sam Gambhir, Stanford University School of Medicine, USA
Sunday, 4 Nov 2018
15:00-00:00
Exhibition - Hall 4
Exhibition opens
Sunday, 4 Nov 2018
15:15-15:45
Exhibition - Hall 4
Coffee break, networking, exhibition and poster viewing
Sunday, 4 Nov 2018
15:20-15:40
Exhibition - Hall 4
Silent Theatres
Sunday, 4 Nov 2018
15:45-15:50
Armadillo - Clyde Auditorium (G)
Welcome speech from Lord Provost
Sunday, 4 Nov 2018
15:50-16:30
Armadillo - Clyde Auditorium (G)
Brain tumours – preclinical to clinical
Speaker: Richard Gilbertson, CRUK Cambridge Institute, UK
Sunday, 4 Nov 2018
16:35-18:35
Hall 1
Tumour immunology and metabolic immunotherapy
Chair: Susan Critchlow, Astrazeneca, UK
Speaker: Martin Miller, CRUK Cambridge Institute, UK
Speaker: Vincenzo Bronte, Federazione Ricerca Biomedica Avanzata Onlus, Italy
Speaker: Saverio Tardito, CRUK Beatson Institute, UK
Sunday, 4 Nov 2018
16:35-18:35
Dochart
Melanoma
Chair: Elizabeth Patton, CRUK Edinburgh Centre
Speaker: David Adams, Wellcome Trust Sanger Institute, UK
Speaker: Richard Marais, CRUK Manchester Institute, UK
Speaker: Richard White, Memorial Sloan Kettering Cancer Centre, USA
Sunday, 4 Nov 2018
16:35-18:35
Carron
Data driven technologies
Chair: David Weller, University of Edinburgh, UK
Speaker: Andrew Morris, Health Data Research UK
Speaker: Alan Karthikesalingam, Deep Mind Health
Speaker: Eva Morris, University of Leeds, UK
Sunday, 4 Nov 2018
16:35-18:35
Seminar Suite
What does multi-morbidity mean for cancer treatment and outcomes
Chair: Peter Murchie, University of Aberdeen, UK
Speaker: Alison Fielding, NCRI Consumer Forum, UK
Speaker: David Blane, University of Glasgow, UK
Speaker: Katriina Whitaker, University of Surrey, UK
Sunday, 4 Nov 2018
16:35-18:35
M1
Cancer research strategy and implementation
Speaker: Tom Crosby, Wales Cancer Network, UK
Speaker: Miriam McCarthy, Health and Social Care Board Northern Ireland, UK
Speaker: David Dunlop, Scottish Government Chief Scientist Office, UK
Speaker: David Fitzgerald, NHS England, UK
Sunday, 4 Nov 2018
16:35-18:35
Boisdale
Modelling the biology of glioblastoma
Chair: Simona Parrinello, University College London, UK
Speaker: Anthony Chalmers, University of Glasgow, UK
Speaker: Steve Pollard, University of Edinburgh, UK
Speaker: Peter Dirks, Sick Kids, Canada
Sunday, 4 Nov 2018
18:40-19:25
Hall 1
Why is cancer so difficult? Understanding and measuring variability
Speaker: Martin Christlieb, University of Oxford, UK
Sunday, 4 Nov 2018
18:40-19:25
Lomond Auditorium
Breast Cancer Now presents ‘Science Simplified’
Sunday, 4 Nov 2018
18:40-19:25
Alsh
NCRI Trainee network event
Sunday, 4 Nov 2018
19:30-21:00
Exhibition - Hall 4
Opening reception, networking, poster and exhibition viewing
Sunday, 4 Nov 2018
19:40-21:00
Exhibition - Hall 4
Silent Theatres
Sunday, 4 Nov 2018
19:45-20:55
Exhibition - Hall 4
Igloo
Monday 5 November
Monday, 5 Nov 2018
08:15-09:00
Carron
Impact on treatment decision depending on method for Liquid Biopsy testing. Comparative study – Agena Bioscience sponsored session
Speaker: Pierre-Jean Lamy, Institut Médical d’Analyse Génomique, Montpellier, France
Monday, 5 Nov 2018
08:15-09:00
Alsh
Demystifying today’s science
Speaker: Elaine Vickers, Science Communicated Ltd, UK
Monday, 5 Nov 2018
08:15-08:45
Exhibition - Hall 4
Relaxation session
Monday, 5 Nov 2018
08:15-09:00
Dochart
Dissecting the tumor microenvironment – tools for cell isolation and flow analysis – Miltenyi Biotec sponsored session
Speaker: Carsten Studte, Global Product Manager, Miltenyi Biotec, UK
Monday, 5 Nov 2018
08:15-09:00
Boisdale
Proffered papers session
Monday, 5 Nov 2018
09:05-09:45
Armadillo - Clyde Auditorium (G)
Why is behavioural change so difficult?
Speaker: Theresa Marteau, University of Cambridge, UK
Monday, 5 Nov 2018
09:45-10:25
Armadillo - Clyde Auditorium (G)
Alcohol, endogenous aldehydes and DNA damage in stem cells
Speaker: KJ Patel, MRC Laboratory of Molecular Biology, UK
Monday, 5 Nov 2018
10:25-11:00
Exhibition - Hall 4
Networking, poster and exhibition viewing
Monday, 5 Nov 2018
10:30-10:55
Exhibition - Hall 4
Igloo
Monday, 5 Nov 2018
10:30-10:55
Exhibition - Hall 4
Silent Theatres
Monday, 5 Nov 2018
11:00-12:30
Hall 1
Recent advances in cancer immunology and immunotherapy
Chair: Sergio Quezada, University College London, UK
Speaker: Nicholas McGranahan, Francis Crick Institute, UK
Speaker: Burkhard Becher, University of Zurich, Switzerland
Speaker: Sine Reker Hadrup, Technical University of Denmark, Denmark
Monday, 5 Nov 2018
11:00-12:30
Alsh
A personalised approach to treating patients with haematological malignancies
Chair: Mhairi Copland, University of Glasgow, UK
Speaker: Anna Schuh, University of Oxford, UK
Speaker: Susanne Saussele, University of Mannheim, Germany
Speaker: Paresh Vyas, University of Oxford, UK
Monday, 5 Nov 2018
11:00-12:30
Boisdale
Liquid biopsies in monitoring treatment
Chair: Nicholas Turner, The Institute of Cancer Research, UK
Speaker: Nitzan Rosenfeld, CRUK Cambridge Institute, UK
Speaker: Johann de Bono, The Institute of Cancer Research, UK
Speaker: Thomas Wurdinger, Neurosurgical Center Amsterdam, The Netherlands
Monday, 5 Nov 2018
11:00-12:30
Seminar Suite
Environmental exposure and cancer prevention
Chair: Linda Bauld, University of Stirling, UK
Speaker: Marion MacFarlane, University of Leicester, UK
Speaker: Lion Shahab, University College London, UK
Speaker: John Cherrie, Heriot Watt University, Edinburgh, UK
Monday, 5 Nov 2018
11:00-12:30
Carron
Proffered papers session (Prize winners)
Monday, 5 Nov 2018
11:00-12:30
Dochart
Genomics in the clinic: Context, care and communication
Chair: Sarah Cunningham-Burley, University of Edinburgh, UK
Speaker: Rikke Sand Anderson, Aarhus University, Denmark
Speaker: Sophie Day, Goldsmiths, University of London, UK
Speaker: Anne Kerr, University of Leeds, UK
Monday, 5 Nov 2018
12:30-14:00
Exhibition - Hall 4
Lunch, networking, exhibition and poster viewing
Monday, 5 Nov 2018
12:40-13:55
Exhibition - Hall 4
Silent Theatres
Monday, 5 Nov 2018
13:00-14:00
Alsh
From research to reality: molecular biomarkers in immuno-oncology – Bristol-Myers Squibb sponsored session
Chair: Gary Middleton, University of Birmingham, UK
Speaker: Mike Hubank, The Royal Marsden, UK
Speaker: John Gosney, Royal Liverpool University Hospital, UK
Monday, 5 Nov 2018
13:00-14:00
M1
Dragons’ den
Monday, 5 Nov 2018
13:00-14:00
Carron
BASO Prizes and Awards session
Monday, 5 Nov 2018
14:00-16:00
Dochart
Myeloid innate immunity
Chair: Jeffrey Pollard, University of Edinburgh, UK
Speaker: Michael Schmid, University of Liverpool, UK
Speaker: Fran Balkwill, Barts Cancer Institute, UK
Speaker: Miki De Palma, Swiss Institute for Experimental Cancer Research, Switzerland
Monday, 5 Nov 2018
14:00-16:00
Boisdale
Cancer vulnerabilities
Chair: Chris Lord, The Institute of Cancer Research, UK
Speaker: Carla Martins, University of Cambridge, UK
Speaker: Jason Moffatt, University of Toronto, Canada
Speaker: Colm Ryan, University College Dublin, Ireland
Monday, 5 Nov 2018
14:00-16:00
Alsh
New approaches to cancer diagnostics, from bench to primary care
Chair: Fiona Walter, University of Cambridge, UK
Speaker: Richard Neal, University of Leeds, UK
Speaker: Steve Pereira, University College London, UK
Speaker: Jon Emery, University of Melbourne, Australia
Monday, 5 Nov 2018
14:00-16:00
Seminar Suite
The role of the surgeon in contemporary cancer research
Chair: Terry Jones, University of Liverpool, UK
Speaker: Alex Mirnezami, University of Southampton, UK
Speaker: Richard Shaw, University of Liverpool, UK
Speaker: Christobel Saunders, University of Western Australia, Australia
Monday, 5 Nov 2018
14:00-16:00
Hall 1
Clinical impact of immunotherapy
Chair: Poulam Patel, University of Nottingham, UK
Speaker: James Larkin, Royal Marsden NHS Foundation Trust, UK
Speaker: Paul Nathan, Mount Vernon Hospital, UK
Speaker: Mary O'Brien, Royal Marsden Hospital, UK
Monday, 5 Nov 2018
14:00-16:00
Lomond Auditorium
The reality of cancer treatment consequences
Chair: David Waller, Alive with Cancer, UK
Chair: Diana Greenfield, Sheffield Teaching Hospitals NHS Foundation Trust, UK
Speaker: Nick Robinson, BBC, Patient representative
Speaker: Adrian Edwards, University of Cardiff, UK
Speaker: Navneet Majhail, Cleveland Clinic, USA
Monday, 5 Nov 2018
14:00-16:00
Carron
Triple negative breast cancer
Chair: Adrian Harris, University of Oxford, UK
Speaker: Jean Abraham, University of Cambridge, UK
Speaker: Roger Daly, Monash University, Australia
Speaker: Peter Schmid, Barts Cancer Institute, UK
Monday, 5 Nov 2018
16:00-16:30
Exhibition - Hall 4
Networking, exhibition and poster viewing
Monday, 5 Nov 2018
16:05-16:30
Exhibition - Hall 4
Igloo
Monday, 5 Nov 2018
16:05-16:30
Exhibition - Hall 4
Silent Theatres
Monday, 5 Nov 2018
16:30-17:45
Lomond Auditorium
Best of translational science: Pancreatic cancer research
Chair: David Chang, University of Glasgow, UK
Speaker: George Miller, New York Langone Medical Center, USA
Speaker: Claus Jorgensen, CRUK, Manchester Institute, UK
Speaker: Jen Morton, CRUK, Beatson Institute, UK
Monday, 5 Nov 2018
16:30-17:45
M1
Clinical Trials Showcase
Monday, 5 Nov 2018
17:50-18:30
Armadillo - Clyde Auditorium (G)
CRUK Prizes session and Lifetime Achievement
Monday, 5 Nov 2018
19:30-23:59
Crowne Plaza Hotel
Conference social event
Tuesday 6 November
Tuesday, 6 Nov 2018
08:15-09:00
Alsh
Demystifying today’s science
Speaker: Elaine Vickers, Science Communicated Ltd, UK
Tuesday, 6 Nov 2018
08:15-09:00
Lomond Auditorium
A career in cancer research: What industry has to offer
Chair: Sue Bailey, Bristol-Myers Squibb, UK
Tuesday, 6 Nov 2018
08:15-08:45
Exhibition - Hall 4
Relaxation session
Tuesday, 6 Nov 2018
08:15-09:00
Carron
Why 3D imaging in preclinical trials is a step forward for cancer research – Fuel3D Sponsored session
Tuesday, 6 Nov 2018
08:15-09:00
Dochart
Proffered papers session
Tuesday, 6 Nov 2018
09:00-15:30
Seminar Suite
Schools event
Tuesday, 6 Nov 2018
09:05-09:45
Armadillo - Clyde Auditorium (G)
Cell function and tumour formation
Speaker: Stefano Piccolo, University of Padua, Italy
Tuesday, 6 Nov 2018
09:45-10:25
Armadillo - Clyde Auditorium (G)
Microbiome and mucosal immunology
Speaker: Fiona Powrie, Kennedy Institute of Rheumatology, UK
Tuesday, 6 Nov 2018
10:25-11:00
Exhibition - Hall 4
Networking, exhibition and poster viewing
Tuesday, 6 Nov 2018
10:30-10:55
Exhibition - Hall 4
Igloo
Tuesday, 6 Nov 2018
10:30-10:55
Exhibition - Hall 4
Silent Theatres
Tuesday, 6 Nov 2018
11:00-12:30
Hall 1
Cancer heterogeneity
Chair: Mariam Jamal-Hanjani, University College London Cancer Institute, UK
Speaker: Peter Van Loo, The Francis Crick Institute, UK
Speaker: Samra Turajlic, The Francis Crick Institute, UK
Speaker: Trevor Graham, Barts Cancer Institute, UK
Tuesday, 6 Nov 2018
11:00-12:30
M1
New cancer therapies
Chair: Caroline Springer, CRUK Manchester Institute, UK
Speaker: Ian Collins, The Institute of Cancer Research, UK
Speaker: John Bell, University of Ottawa, Canada
Speaker: Allan Jordan, CRUK Manchester Institute, UK
Tuesday, 6 Nov 2018
11:00-12:30
Carron
Population cancer screening: are we getting it right?
Chair: Ian Tomlinson, University of Birmingham, UK
Speaker: Linda Sharp, Newcastle University, UK
Speaker: Mette Kalager, University of Oslo, Norway
Speaker: Richard Martin, University of Bristol, UK
Tuesday, 6 Nov 2018
11:00-12:30
Boisdale
The promise of precision
Chair: Tim Maughan, University of Oxford, UK
Speaker: Peter O'Dwyer, University of Pennsylvania, USA
Speaker: Cindy Billingham, University of Birmingham, UK
Speaker: Rodrigo Dienstmann, Vall d'Hebron Institut d’Oncologia, Barcelona, Spain
Tuesday, 6 Nov 2018
11:00-12:30
Alsh
Spotlight on NCRI activities: Living with and beyond cancer initiative
Chair: Richard Stephens, NCRI Consumer Forum, UK
Speaker: Andrew Bottomley, European Organisation for Research and Treatment of Cancer (EORTC), Belgium
Speaker: Sam Ahmedzai, University of Sheffield, UK
Speaker: Ceinwen Giles, Shine Cancer Support, UK
Speaker: Galina Velikova, University of Leeds, UK
Tuesday, 6 Nov 2018
11:00-12:30
Dochart
Digital pathology
Chair: Karin Oien, University of Glasgow, UK
Speaker: Manuel Salto-Tellez, Queen's University Belfast, UK
Speaker: Nasir Rajpoot, University of Warwick, UK
Speaker: Yinyin Yuan, The Institute of Cancer Research, UK
Tuesday, 6 Nov 2018
12:30-14:00
Exhibition - Hall 4
Lunch, networking, exhibition and poster viewing
Tuesday, 6 Nov 2018
12:40-13:55
Exhibition - Hall 4
Silent Theatres
Tuesday, 6 Nov 2018
13:00-14:00
Boisdale
Proffered papers session
Tuesday, 6 Nov 2018
13:00-14:00
Lomond Auditorium
Meet the expert
Chair: Owen Sansom, CRUK, Beatson Institute, UK
Speaker: Gemma Pearce, Coventry University, UK
Speaker: Linda Bauld, University of Stirling, UK
Speaker: Pippa Corrie, Cambridge University Hospitals, UK
Speaker: Maria Hawkins, CRUK MRC Oxford Institute for Radiation Oncology, UK
Speaker: Terry Jones, University of Liverpool, UK
Speaker: Chris Lord, The Insitute of Cancer Research, UK
Speaker: Elizabeth Patton, CRUK Edinburgh Centre, UK
Tuesday, 6 Nov 2018
13:00-14:00
Alsh
Advances in pancreatic and biliary tract cancers: investigators’ perspectives – NuCana sponsored workshop
Speaker: Mairéad McNamara, Christie Hospital, Manchester, UK
Speaker: Juan W. Valle, Christie Hospital Manchester, UK
Speaker: Dan Palmer, University of Liverpool & Clatterbridge Cancer Centre
Tuesday, 6 Nov 2018
14:00-16:00
Boisdale
Understanding the role of TGFbeta signaling in cancer
Chair: Gareth Inman, University of Dundee, UK
Speaker: Joan Seoane, Val D’Hebron Institute of Oncology, Spain
Speaker: Caroline Hill, The Francis Crick Institute, UK
Speaker: Carl-Henrik Heldin, The Ludwig Institute for Cancer Research, UK
Tuesday, 6 Nov 2018
14:00-16:00
M1
Impact of a patient’s gut microbiome on clinical response to cancer immunotherapy
Chair: Trevor Lawley, Wellcome Trust Sanger Institute
Speaker: Robert Jenq, MD Anderson Cancer Center, USA
Speaker: Trevor Lawley, Wellcome Trust Sanger Institute, UK
Speaker: Paul O'Toole, University College Cork, Ireland
Tuesday, 6 Nov 2018
14:00-16:00
Hall 1
The burden of cancer due to inequalities and its likely causes
Chair: Yoryos Lyratzopoulos, University College London, UK
Speaker: Jo Waller, University College London, UK
Speaker: Nancy Keating, Harvard Medical School and Dana Farber. USA
Speaker: Bernard Rachet, London School of Hygiene and Tropical Medicine, UK
Tuesday, 6 Nov 2018
14:00-16:00
Alsh
Radiotherapy combinations
Chair: Maria Hawkins, CRUK MRC Oxford Institute for Radiation Oncology, UK
Speaker: Kaye Williams, The University of Manchester, UK
Speaker: Susan Short, University of Leeds, UK
Speaker: Alan Melcher, The Institute of Cancer Research, UK
Tuesday, 6 Nov 2018
14:00-16:00
Lomond Auditorium
The challenge of rare cancers
Chair: Richard Adams, University of Cardiff, UK
Speaker: Sheela Rao, Royal Marsden Hospital, UK
Speaker: Matt Sydes, University College London, UK
Speaker: Steve Nicholson, International Rare Cancers Initiative in Penile Cancer, UK
Tuesday, 6 Nov 2018
14:00-16:00
Dochart
Measuring what matters to healthcare professionals, patients and service providers
Chair: Lesley Fallowfield, University of Sussex, UK
Speaker: Derek Kyte, University of Birmingham, UK
Speaker: David Cella, CORE Core Outcomes Research Centre, Chicago, USA
Speaker: Jane Blazeby, University of Bristol, UK
Tuesday, 6 Nov 2018
14:00-16:00
Carron
Ovarian cancer – novel models and novel targets
Chair: Iain McNeish, Imperial College London, UK
Speaker: Ahmed Ahmed, University of Oxford, UK
Speaker: Stephen Taylor, University of Manchester, UK
Speaker: Charlie Gourley, University of Edinburgh, UK
Tuesday, 6 Nov 2018
16:00-16:30
Exhibition - Hall 4
Networking, exhibition and poster viewing
Tuesday, 6 Nov 2018
16:05-16:30
Exhibition - Hall 4
Igloo
Tuesday, 6 Nov 2018
16:05-16:30
Exhibition - Hall 4
Silent Theatres
Tuesday, 6 Nov 2018
16:30-17:10
Armadillo - Clyde Auditorium (G)
Head and neck cancer treatments
Speaker: Quynh-Thu Le, Stanford University, USA
Tuesday, 6 Nov 2018
17:10-17:30
Armadillo - Clyde Auditorium (G)
Closing remarks